Teleflex Incorporated (TFX) has disseminated its third-quarter results, leading to adjustments in analysts' forecasts. Furthermore, the firm announced a quarterly dividend, and DekaBank Deutsche Girozentrale divested 101,150 shares. TFX has given its 2024 annual outlook alongside its third-quarter earnings. Despite topping Q3 predictions, the company's stock fell due to a lowered 2024 revenue outlook. The firm, however, remains a valuable stock for long-term investment owing to a Q3 increase in revenue and plans for share buybacks. Teleflex has launched its next-generation
Arrow™ VPS Rhythm™ DLX Device and
NaviCurve™ Stylet in Canada. In addition, the firm plans a pay-out on December 16, 2024. A significant increase in short interest, supply chain management integration with
o9’s AI-Powered Platform, and launch of new vascular access devices in Canada all suggest Teleflex's strategic growth path. In contrast, Q3 performance missed some targets, instigating
Truist to cut their target to $227. Premier Inc has conferred Hemostasis Products Agreements on the firm; their
Barrigel Rectal Spacer will feature in presentations at the 2024 American Society for Radiation Oncology (ASTRO) Annual Meeting. Finally, Teleflex acquisitions include
Palette Life Sciences, with the first patient enrolment in the Barrigel™ Rectal Spacer Study reflecting their ongoing clinical exploration and commitment.
Teleflex Incorporated TFX News Analytics from Fri, 22 Jun 2018 07:21:52 GMT to Sat, 02 Nov 2024 17:41:54 GMT -
Rating 3
- Innovation 5
- Information 7
- Rumor 4
